Risks of long-term vision loss after trabeculectomy identified

Article

Risk factors for long-term vision loss after trabeculectomy included preoperative split fixation on visual fields

Risk factors for long-term vision loss after trabeculectomy included preoperative split fixation on visual fields, according to a study published in the Archives of Ophthalmology.

The study led by Dr Brian A. Francis, Department of Ophthalmology, Doheny Eye Institute, Los Angeles, California, USA, investigated the medical records of 301 eyes in 262 patients who underwent trabeculectomy between January 1999 and September 2003. Mild or moderate postoperative vision loss was categorized by a decrease in Snellen acuity of 3 – 5 lines. Permanent postoperative vision loss was identified if visual acuity did not return to 3 lines within the 6-month follow up period.

Of the 301 eyes studied, 24 suffered from permanent vision loss, 13 presented with mild or moderate vision loss and 11 experienced severe vision loss. Permanent mild or moderate vision loss in 10 eyes and permanent severe vision loss 6 eyes had no identifiable cause.

Transient vision loss was experienced in 170 eyes. This consisted of 79 eyes with mild or moderate vision loss and 91 eyes with severe vision loss. The mean recovery times were 88 days and 78 days, respectively.

The risk factors identified in the study included preoperative split fixation on visual fields, preoperative number of quadrants with split fixation, and postoperative choroidal effusions with eventual resolution.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.